Page 4 - Array Biopharma News Today

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

By Colin Kellaher Pfizer Inc. on Tuesday said the U.S. Food and Drug Administration has accepted for review applications seeking expanded approval of the combination of its Braftovi and... | April 4, 2023

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue. The pharmaceutical giant said Monday it will pay $229 ...

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue. The pharmaceutical giant said Monday it will pay

Pfizer plans to let the biotech drug developer continue innovating, except with more resources. Seagen's key products use monoclonal antibodies that help deliver a cancer-killing drug while sparing surrounding tissue.

Pfizer buys Seagen for $43B, boosts access to cancer drugs from 41NBC News | WMGT-DT

Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer

Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue

Drugmaker seeks out new revenue sources as expiration of patents protecting drugs like Ibrance from competition nears.

Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer